Feb 1, 2022 ForeScout Technologies has entered into an agreement to acquire CyberMDX . ForeScout Technologies based at San Jose, California, United States. “Forescout actively […]
Series A – Biofidelity
On Feb 1, 2022 Biofidelity closed a Series A round and raised $23,000,000 from Octopus Ventures, SBI Investment, featuring lead investors Octopus Ventures. About the […]
Venture Round – Phylos
On Feb 1, 2022 Phylos closed a Venture – Series Unknown round and raised $7,600,000 from Accomplice, Entourage Effect Capital, Merida Capital Holdings, featuring lead […]
Post-IPO Debt – IntelGenX
On Feb 1, 2022 IntelGenX closed a Post-IPO Debt round and raised $3,000,000 from ATAI Life Sciences, featuring lead investors ATAI Life Sciences. About the […]
Post-IPO Debt – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Debt round and raised $45,000,000 from Oxford Finance LLC, featuring lead investors Oxford Finance LLC. About the […]
Post-IPO Equity – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Equity round and raised €15,000,000 from Careventures, DPE Deutsche Private Equity, TVM Capital Life Science, featuring lead […]
Series B – ethris
On Feb 1, 2022 ethris closed a Series B round and raised €23,300,000 from Laureus Capital, featuring lead investors Laureus Capital. About the company: ethris […]
Venture Round – Talking Medicines
On Feb 1, 2022 Talking Medicines closed a Venture – Series Unknown round and raised £1,500,000 from Mark Bamforth, Scottish Enterprise, SIS Ventures, Tern, featuring […]
Series A – Biofidelity
On Feb 1, 2022 Biofidelity closed a Series A round and raised $23,000,000 from Octopus Ventures, SBI Investment, featuring lead investors Octopus Ventures. About the […]
Venture Round – Phylos
On Feb 1, 2022 Phylos closed a Venture – Series Unknown round and raised $7,600,000 from Accomplice, Entourage Effect Capital, Merida Capital Holdings, featuring lead […]
